GPNMB and brain disorder: Forty-one protein-coding genes (PLCD3, GPNMB, KHK, NEK4, PLCG1, TIE1, PPCDC, RSPO3, RCSD1, TMEM106B, etc.)may serve as potential drug targets, whose expression are associated with neurodevelopmental and brain disorders.